Abeona Therapeutics Inc. (Nasdaq:ABEO) has opened The Elisa Linton Center for Rare Disease Therapies, a 6,000-square-foot commercial manufacturing facility for gene and cell therapies in Cleveland.
The clinical-stage biopharmaceutical company, which focuses on developing novel gene and cell therapies for life-threatening rare diseases, announced last year it would construct the facility in the hopes of creating life-saving treatments out of its own manufacturing facility.
Click here to read the complete article.
Story excerpt provided by Crain’s Cleveland Business. Written by Lydia Coutre. Originally published June 11, 2018.